๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI ยท Real-Time Price ยท USD
2.790
-0.081 (-2.82%)
At close: Nov 19, 2026, 4:00 PM EST
2.400
-0.390 (-13.98%)
Pre-market: Nov 20, 2026, 4:59 AM EST

SNTI Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.070.02-2.564.292.76
Revenue Growth
----40.25%55.23%387.81%
Gross Profit
-7.69-37.56-34.36-29.59-23.86-19.2
Operating Income
-46.13-58.3-54.28-64.44-62.08-40.45
Net Income
-43.02-61.44-55.31-71.06-58.21-55.32
Earnings Per Share
-1.43-90.18-397.15-528.48-735.68-
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5.5516.7448.6135.9799.7757.19
Total Debt
21.5628.8933.5437.6737.0922.73
Net Cash (Debt)
-16.01-12.1615.07-1.762.6834.46
Net Cash Growth
----81.89%108.68%
Net Cash Per Share
-0.53-17.84108.24-12.63792.19-

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-35.33-43.44-41.4-52.4-34.9-34.64
Capital Expenditures
--0.2-0.03-12.04-41.37-5.54
Free Cash Flow
-35.33-43.64-41.42-64.43-76.27-40.18
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-62343.24%-265018.18%--2516.28%-1448.53%-1464.90%
Pretax Margin
-58140.54%-279263.64%--3256.77%-1158.77%-2003.59%
Profit Margin
-58140.54%-279263.64%--2774.62%-1358.14%-2003.59%
FCF Margin
-47745.95%-198363.64%--2515.93%-1779.51%-1455.20%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
35.581242.84-11.4814.43105.23